Tag: Dr. Oliver Schacht
Company News: Curetis Strengthens Executive Team; Appoints Dr. Achim Plum as Chief Commercial Officer
– Former Siemens Healthcare manager adds broad expertise in molecular diagnostics, sales, marketing, and business development
Curetis AG, a developer of next-level molecular diagnostic solutions, today announced Dr. Achim Plum has been appointed to the newly-created role of Chief Commercial Officer. Dr. Plum joins Curetis from a senior management position at Siemens, where he focused on the assessment and development of novel approaches to the in vitro diagnostic (IVD) market. He will oversee all commercial activities, including international sales, business development, marketing and medical affairs.
Dr. Plum will focus on the continued expansion of Curetis’ commercial organization and infrastructure with the goal of achieving aggressive revenue growth targets in Europe, Asia and the rest of the world. He will also establish a U.S.-based commercial team to support the launch of the Unyvero Solution following FDA approval.
Prior to his position at Siemens, Dr. Plum spent eight years in various commercial roles at Epigenomics, a publicly-traded molecular diagnostics company, most recently as Senior Vice President Business and Strategy. At Epigenomics, he built sales and marketing teams and distribution networks in Europe and the U.S., negotiated strategic commercial agreements with leading diagnostics industry players and led the public company’s corporate communications and compliance functions. He brings significant capital markets experience through his involvement in multiple financing transactions with U.S. and international investors.